Comparing two creams for facial melasma
Part of Skin clinical trials.
This study compares two creams — metformin and tranexamic acid — to see which works better for melasma (dark patches on the face). If you qualify, you'll use one of the creams and your progress will be checked over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 50 years old.
- You must have melasma on your face, diagnosed by a doctor.
- You cannot be pregnant or breastfeeding.
- You must not have used any melasma treatments (on your skin or by mouth) in the last 4 weeks.
- You must not be allergic to the study medicines.
- You must not have other skin conditions on your face or a history of skin reactions to sunlight.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a metformin cream to a standard treatment (Kligman's regimen) for reducing melasma, a common skin condition causing dark patches on the face. It aims to find which treatment is more effective for women with this condition.
This study compares two treatments for melasma: injecting tranexamic acid into the skin versus applying a mandelic acid facial peel. The goal is to see which one works better at lightening the dark patches on your face.
This study compares two different creams applied to the skin — metformin and ketotifen — to see which works better for treating melasma (dark patches on the face). If you are a woman with melasma, you may be eligible to join and receive one of these creams.
This study compares two topical creams — one with tranexamic acid and one with vitamin C (ethyl ascorbic acid) — to see which works better for treating melasma. If you have melasma and meet the health criteria, you may be able to join and receive one of these treatments.
This study tests whether adding an oral medicine (tranexamic acid) to a standard triple cream works better for melasma than the cream alone. It may help lighten dark patches on your skin if you have the right type of melasma.
This study compares two different combination creams for treating melasma, a common skin condition causing dark patches on the face. One cream includes a mild steroid and the other has a different steroid, both with the same lightening ingredients. The goal is to see which works better and is safer for your skin.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.